Home/Filings/4/0001104659-22-082286
4//SEC Filing

Maraoui Claude 4

Accession 0001104659-22-082286

CIK 0001867066other

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 9:34 AM ET

Size

14.4 KB

Accession

0001104659-22-082286

Insider Transaction Report

Form 4
Period: 2022-07-21
Maraoui Claude
DirectorPresident & CEO
Transactions
  • Award

    Common Stock, par value $0.0001 per share

    2022-07-21+300,0002,192,530 total
Footnotes (2)
  • [F1]On July 21, 2022, the reporting person was granted 300,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan. One-fourth of the shares will vest on each of July 21, 2023, 2024, 2025 and 2026, subject to the reporting person's continuous service with the Issuer.
  • [F2]Includes 742,530 restricted stock units, 300,000 of which will vest over various time periods as set forth in footnote 1, and 442,530 of which will vest in accordance with the following schedule: 147,362 shares on the fifteenth day of the eighteenth month following the closing of the Issuer's initial public offering (the "Tranche 1 Vesting Date"); 147,362 of which will vest nine months after the Tranche 1 Vesting Date (the "Tranche 2 Vesting Date"), and 147,806 of which will vest nine months after the Tranche 2 Vesting Date.

Issuer

Journey Medical Corp

CIK 0001867066

Entity typeother

Related Parties

1
  • filerCIK 0001893880

Filing Metadata

Form type
4
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 9:34 AM ET
Size
14.4 KB